Assyro AI

FDA Orange Book · active-ingredient family

Urea c-13

Urea c-13 is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

3

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · for solution

ProductApplicantApplicationTEApproved
BREATHTEK UBT FOR H-PYLORI×2OTSUKA AMERICANDA 020586May 10, 2001
HELICOSOLMETABOLIC SOLUTIONSNDA 021092Dec 17, 1999
PYLORI-CHEK BREATH TESTDXS DEVICESNDA 020900Feb 04, 1999

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Urea c-13 — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.